Does SIMVASTATIN Cause Coronary arterial stent insertion? 10 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Coronary arterial stent insertion have been filed in association with SIMVASTATIN (Simvastatin). This represents 0.0% of all adverse event reports for SIMVASTATIN.
10
Reports of Coronary arterial stent insertion with SIMVASTATIN
0.0%
of all SIMVASTATIN reports
0
Deaths
2
Hospitalizations
How Dangerous Is Coronary arterial stent insertion From SIMVASTATIN?
Of the 10 reports, 2 (20.0%) required hospitalization.
Is Coronary arterial stent insertion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SIMVASTATIN. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does SIMVASTATIN Cause?
Myalgia (3,919)
Fatigue (2,066)
Arthralgia (1,775)
Drug interaction (1,744)
Nausea (1,676)
Rhabdomyolysis (1,616)
Dyspnoea (1,542)
Headache (1,470)
Drug hypersensitivity (1,433)
Muscular weakness (1,356)
What Other Drugs Cause Coronary arterial stent insertion?
ROSIGLITAZONE (1,698)
METFORMIN\ROSIGLITAZONE (245)
ADALIMUMAB (175)
EVOLOCUMAB (109)
RANOLAZINE (95)
RISANKIZUMAB-RZAA (94)
AVANDIA (68)
ETANERCEPT (67)
IBRUTINIB (54)
UPADACITINIB (52)
Which SIMVASTATIN Alternatives Have Lower Coronary arterial stent insertion Risk?
SIMVASTATIN vs SINGULAIR
SIMVASTATIN vs SINTILIMAB
SIMVASTATIN vs SIPONIMOD
SIMVASTATIN vs SIPULEUCEL-T
SIMVASTATIN vs SIROLIMUS